ArticleInternational journal of clinical and experimental pathology2025
Clinicopathologic characteristics and outcome of gastric-type endocervical adenocarcinoma: a single-center retrospective study.
Article in International journal of clinical and experimental pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gastric-Type Cervical Adenocarcinoma: Clinicopathologic Features, Molecular Landscape, and Therapeutic Challenges.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the clinical and pathological characteristics of gastric-type endocervical adenocarcinoma (G-EAC) to advance the early diagnosis and treatment of this disease.
methodsThe diagnosis, treatment, follow-up, pathological morphology, immunohistochemical characteristics and other data of 15 patients of G-EAC visiting our hospital from December 2016 to March 2024 were retrospectively analyzed, and the relevant literature was discussed.
resultsThe mean age of participants was 45.13 years. There were four cases with vaginal discharge, eight cases with spontaneous vaginal contact bleeding, one case where hysterosalpingography (HSG) demonstrated uterine cavity fluid accumulation, and two cases of abdominal pain and swelling with pelvic mass (one with fever) as the initial symptom. There were two participants with Peutz-Jeghers syndrome (PJS). Histologically speaking, G-EAC exhibited various morphologic characteristics, including well-differentiated glands and unusual glands dispersed randomly within the cervical stroma and lacking lobular structures. Neutrophil infiltration and glandular abscess formation were commonly observed. Immunohistochemical analysis showed no expression of ER, PR, or NapsinA, but varying degrees of CK7, MUC6, MUC5AC, CEA, HNF1β, and PAX-8 expression. During the follow-up, which lasted from 1 to 88 months, 2 participants died after 6 months and 10 months respectively. Moreover, 5 participants exhibited distant metastasis, and the remaining 8 participants were healthy and disease free.
conclusionG-EAC is an uncommon subtype of cervical adenocarcinoma that frequently manifests as an advanced-stage cancer with vague clinical symptoms, making biopsy-based diagnosis challenging. Since conventional treatments demonstrated limited efficacy, clinicians and pathologists should pay particular attention to this entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.